The average out-of-pocket research and development (R&D) cost per approved new compound has grown to more than $2.8 billion. Life sciences companies are turning to IT to help counteract this trend by accelerating drug development speed while reducing costs. Industry leaders have found success using APIs to build a digital platform strategy for R&D innovation, enabling more effective and efficient collaboration with investigators, CROs, and other trial stakeholders.
Read this whitepaper to learn:
- A 4-step digital platform strategy for life sciences companies to accelerate product development with APIs.
- Digital platform considerations to help life sciences IT select technology and talent for R&D.
- How a leading pharmaceutical used APIs to share data across its network of investigators and CROs.